TEVA PHARMACEUTICAL INDUSTRIES LIMITED Proceeds from Debt, Net of Issuance Costs
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Proceeds from Debt, Net of Issuance Costs of $2.30 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from debt, net of issuance costs for the quarter ending 2025-06-30 was $2.31B.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from debt, net of issuance costs for the quarter ending 2024-12-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from debt, net of issuance costs for the quarter ending 2024-09-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from debt, net of issuance costs for the quarter ending 2024-06-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from debt, net of issuance costs for fiscal 2025 was $2.30B.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from debt, net of issuance costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from debt, net of issuance costs for fiscal 2023 was $2.45B.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from debt, net of issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.30B 10-K · filed 2026-02-03 | |||
| 2025-06-30 | $2.31B 10-Q · filed 2025-07-30 | $2.31B 10-Q · filed 2025-07-30 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $0.00 derived: sum of 2 quarters · filed 2026-02-03 | $0.00 derived: sum of 3 quarters · filed 2026-02-03 | $0.00 10-K · filed 2026-02-03 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-07-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-02-03 | $0.00 derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-03 | $0.00 derived: sum of 3 quarters · filed 2026-02-03 | $0.00 derived: sum of 4 quarters · filed 2026-02-03 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $0.00 derived: sum of 2 quarters · filed 2026-02-03 | $0.00 derived: sum of 3 quarters · filed 2026-02-03 | $2.45B 10-K · filed 2026-02-03 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $2.45B 10-Q · filed 2024-11-06 | $2.45B derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-31 | $2.45B 10-Q · filed 2024-07-31 | $2.45B derived: sum of 3 quarters · filed 2025-02-05 | $2.45B derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-03-31 | $2.45B 10-Q · filed 2024-05-08 | $2.45B derived: sum of 2 quarters · filed 2025-02-05 | $2.45B derived: sum of 3 quarters · filed 2025-02-05 | $2.45B derived: sum of 4 quarters · filed 2025-02-05 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $0.00 derived: sum of 2 quarters · filed 2025-02-05 | $0.00 derived: sum of 3 quarters · filed 2025-02-05 | $0.00 10-K · filed 2025-02-05 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | $0.00 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $4.97B 10-K · filed 2024-02-12 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-10 | |||
| 2019-12-31 | $2.08B 10-K · filed 2022-02-09 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | -$1.00M derived: sum of 2 quarters · filed 2021-02-10 | -$6.00M derived: sum of 3 quarters · filed 2021-02-10 | $4.43B 10-K · filed 2021-02-10 |
| 2018-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$6.00M derived: sum of 2 quarters · filed 2019-11-07 | $4.43B 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $4.43B 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $4.44B 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $506.00M 10-K · filed 2020-02-21 | |||
| 2016-12-31 | $25.25B 10-K · filed 2019-02-19 |